Imrab 3 - 1905.20
40 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
40
Total Reports
1
Deaths Reported
250.0%
Death Rate
Active Ingredients
Imrab 3 - 1905.20
Administration Routes
SubcutaneousUnknownIntramuscular
Species Affected
Dog 33
Horse 4
Cat 3
Most Affected Breeds
Crossbred Canine/dog 6
Dachshund (unspecified) 3
Quarter Horse 3
Chihuahua 3
Poodle - Miniature 2
Shih Tzu 2
Beagle 2
Schnauzer - Miniature 2
Domestic Longhair 2
Shepherd Dog - Australian 2
Most Reported Reactions
Vomiting 14
Lethargy (see also Central nervous system depression in 'Neurological') 10
Loose stool 5
Other abnormal test result NOS 5
Colic 4
Behavioural disorder NOS 4
Diarrhoea 4
Anorexia 4
Abdominal pain 3
Not eating 3
Itching 3
Injection site pain 3
Outcome Breakdown
Outcome Unknown
18 (45.0%)
Recovered/Normal
18 (45.0%)
Ongoing
3 (7.5%)
Died
1 (2.5%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.